Yohimbine for Health & Longevity - Quick Reference Sheet

Yohimbine for Health & Longevity

Created on 09/22/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5 – Audit

Yohimbine is a plant compound from West African tree bark, sold as a supplement for fat loss and alertness and used for decades as a medicine for difficulty getting an erection. Evidence supports a modest erection benefit; fat-loss claims rest on thin ground and longevity claims are speculative. It reliably raises heart rate and blood pressure and can trigger anxiety, and product content varies widely. (Full Review)

Protocol

Erectile-dysfunction protocol (historical clinical standard)
5.4 mg three times daily
Roughly 16 mg/day total, used continuously for several weeks to judge response.
Fat-loss protocol (fitness-practitioner standard)
~0.2 mg/kg, fasted
Before morning fasted cardiovascular exercise; food, especially carbohydrate, avoided around dosing.
Best time of day
Morning or pre-workout
Evening use is discouraged; morning dosing avoids sleep disruption.
Time to effect
Erectile response
Within an hour
Continuous use for several weeks to judge response.
Body-composition change
Weeks
If it occurs at all; requires consistent fasted use combined with exercise.
Alertness and heart rate
Within an hour
Acute only; parent-compound half-life roughly 0.5–1 hour.

Benefits

Contraindications
  • Monoamine oxidase inhibitors (phenelzine, tranylcypromine, selegiline)
  • Cardiovascular disease, arrhythmias, recent heart attack
  • Uncontrolled or moderately elevated hypertension (≥140/90 mmHg)
  • Anxiety or panic disorder, post-traumatic stress disorder
  • Bipolar disorder, schizophrenia
  • Kidney disease (eGFR <60 mL/min/1.73m²)
  • Significant liver impairment (Child-Pugh Class B or C)
  • Pregnancy or breastfeeding
Key Interactions
  • Other stimulants and sympathomimetics (caffeine, synephrine, ephedrine, pseudoephedrine, amphetamines)
  • Tricyclic antidepressants (amitriptyline, clomipramine) and some SSRIs (fluoxetine, sertraline)
  • Antihypertensive medications (clonidine and alpha-2 agonists, beta-blockers, ACE inhibitors)
  • Other erectogenic agents (PDE5 inhibitors such as sildenafil; intracavernosal agents)
  • Naltrexone and other agents used in addiction/stress research
  • Over-the-counter decongestants and "energy"/weight-loss products
  • Thermogenic supplements (caffeine, synephrine, green-tea extract)

Risk & Side Effects

  • High: Anxiety, agitation, and panic; cardiovascular stimulation: tachycardia and hypertension
  • Medium: Insomnia and overstimulation; gastrointestinal distress and nausea; headache and dizziness
  • Low: Hypertensive crisis and serious cardiac events; priapism
  • Speculative: Precipitation of mania or psychosis

Monitoring

Marker Target Why
Resting blood pressure <120/80 mmHg Yohimbine raises blood pressure; sets a safety baseline and a stop threshold
Resting heart rate 50–70 bpm Yohimbine is a stimulant that can cause tachycardia (fast heart rate)
Fasting glucose 70–90 mg/dL Adrenergic stimulation can transiently raise glucose and blunt fat loss
eGFR (estimated kidney filtration) >90 mL/min/1.73m² Reduced kidney clearance raises drug exposure and side-effect risk

Cadence: Blood pressure and heart rate before and about 1–2 hours after dosing during the first 1–2 weeks, then weekly for the first month, then every 3–6 months if use continues; reassess promptly after any dose increase or new stimulant exposure.

Qualitative Assessment

  • Energy and alertness: a useful lift without feeling "wired."
  • Anxiety and jitteriness: any rise is an early warning to reduce or stop.
  • Sleep quality: onset and continuity should be unaffected; disruption signals dosing too late or too high.
  • Erectile function (if that is the goal): improvement in firmness and reliability.
  • Stubborn-fat and waist changes (if fat loss is the goal): slow changes in waist measurement or lower-body fat over weeks, not days.